OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ditans vs Gepants
Alok Singh, Dhyuti Gupta, Abhishek Singh
Neurology India (2021) Vol. 69, Iss. Suppl 1, pp. S43-S50
Closed Access | Times Cited: 8
Alok Singh, Dhyuti Gupta, Abhishek Singh
Neurology India (2021) Vol. 69, Iss. Suppl 1, pp. S43-S50
Closed Access | Times Cited: 8
Showing 8 citing articles:
Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 255-265
Open Access | Times Cited: 28
Hannah A. Blair
CNS Drugs (2023) Vol. 37, Iss. 3, pp. 255-265
Open Access | Times Cited: 28
Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis
William Kristian Karlsson, Edoardo G. Ostinelli, Zixuan Alice Zhuang, et al.
BMJ (2024), pp. e080107-e080107
Closed Access | Times Cited: 16
William Kristian Karlsson, Edoardo G. Ostinelli, Zixuan Alice Zhuang, et al.
BMJ (2024), pp. e080107-e080107
Closed Access | Times Cited: 16
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein
BioDrugs (2022) Vol. 36, Iss. 3, pp. 341-358
Open Access | Times Cited: 29
Fred Cohen, Hsiangkuo Yuan, Stephen D. Silberstein
BioDrugs (2022) Vol. 36, Iss. 3, pp. 341-358
Open Access | Times Cited: 29
New Approaches to Shifting the Migraine Treatment Paradigm
Brian F. G. Johnson, Frederick G. Freitag
Frontiers in Pain Research (2022) Vol. 3
Open Access | Times Cited: 18
Brian F. G. Johnson, Frederick G. Freitag
Frontiers in Pain Research (2022) Vol. 3
Open Access | Times Cited: 18
Emerging experimental drugs in clinical trials for migraine: observations and key talking points
William David Wells-Gatnik, Tiffany Y. Wences Chirino, Fatma Nur Onan, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 761-771
Closed Access | Times Cited: 5
William David Wells-Gatnik, Tiffany Y. Wences Chirino, Fatma Nur Onan, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 761-771
Closed Access | Times Cited: 5
Rimegepant for the acute and preventive treatment of migraine: a narrative review of the evidence
Lars Edvinsson
Expert Review of Neurotherapeutics (2024), pp. 1-15
Open Access
Lars Edvinsson
Expert Review of Neurotherapeutics (2024), pp. 1-15
Open Access
Efficacy and safety of ivermectin for COVID-19
Alok Singh, Pranav G. Sheth, Suryaprakash Dhaneria, et al.
Asian Pacific Journal of Tropical Medicine (2021) Vol. 14, Iss. 10, pp. 440-450
Open Access | Times Cited: 3
Alok Singh, Pranav G. Sheth, Suryaprakash Dhaneria, et al.
Asian Pacific Journal of Tropical Medicine (2021) Vol. 14, Iss. 10, pp. 440-450
Open Access | Times Cited: 3
New Gepants Against Acute Migraine
Dhyuti Gupta, Suryaprakash Dhaneria, Alok Singh
Amrita Journal of Medicine (2021) Vol. 17, Iss. 4, pp. 109-115
Open Access | Times Cited: 1
Dhyuti Gupta, Suryaprakash Dhaneria, Alok Singh
Amrita Journal of Medicine (2021) Vol. 17, Iss. 4, pp. 109-115
Open Access | Times Cited: 1
